In 2023, Novo Nordisks Ozempic and Wegovy generated $13.9 billion and $4.6 billion, respectively, while Eli Lillys Trulicity and Mounjaro generated $7.1 billion and $5.1 billion. By 2030, Eli Lilly is expected to surpass Novo Nordisk, becoming the leading company in GLP-1R sales with $67.7 billion
Yes, you breathe in the toxins, but the lungs are more resilient-they will damage the gut lining fairly rapidly
Furthermore, a decrease in the content and change in the composition of intercellular lipids, especially ceramides, increases transepidermal water loss (TEWL) and facilitates the penetration of external allergens and microbes (Almeida et al
A Triple-Cellular Reset, in one daily scoop
Once released in the body, it attaches to the pituitary gland receptors
These medications mimic a hormone your body already produces, which tells your brain youre full, slows down digestion, and helps regulate blood sugar after you eat